BRPI0815500A2 - compostos terapêuticos, bem como seus usos - Google Patents

compostos terapêuticos, bem como seus usos

Info

Publication number
BRPI0815500A2
BRPI0815500A2 BRPI0815500A BRPI0815500A BRPI0815500A2 BR PI0815500 A2 BRPI0815500 A2 BR PI0815500A2 BR PI0815500 A BRPI0815500 A BR PI0815500A BR PI0815500 A BRPI0815500 A BR PI0815500A BR PI0815500 A2 BRPI0815500 A2 BR PI0815500A2
Authority
BR
Brazil
Prior art keywords
well
therapeutic compounds
therapeutic
compounds
Prior art date
Application number
BRPI0815500A
Other languages
English (en)
Inventor
W Gil Daniel
G Gomez Dario
G Corpuz Evelyn
Chow Ken
C Sinha Santosh
S Bhat Smita
M Heidelbaugh Todd
K Fang Wenkui
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0815500A2 publication Critical patent/BRPI0815500A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
BRPI0815500A 2007-08-15 2008-08-14 compostos terapêuticos, bem como seus usos BRPI0815500A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95596407P 2007-08-15 2007-08-15
PCT/US2008/073108 WO2009023757A1 (en) 2007-08-15 2008-08-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
BRPI0815500A2 true BRPI0815500A2 (pt) 2017-05-30

Family

ID=39930736

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815500A BRPI0815500A2 (pt) 2007-08-15 2008-08-14 compostos terapêuticos, bem como seus usos

Country Status (10)

Country Link
US (1) US20110178143A1 (pt)
EP (1) EP2188261A1 (pt)
JP (2) JP2010536780A (pt)
KR (1) KR20100046256A (pt)
CN (1) CN101855213B (pt)
AU (1) AU2008286823A1 (pt)
BR (1) BRPI0815500A2 (pt)
CA (1) CA2696404A1 (pt)
RU (1) RU2491278C2 (pt)
WO (1) WO2009023757A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0816158A2 (pt) * 2007-08-15 2017-06-13 Allergan Inc composto carbociclo fundido substituído com heterociclila e uso do mesmo.
US20120309796A1 (en) 2011-06-06 2012-12-06 Fariborz Firooznia Benzocycloheptene acetic acids
US20150166528A1 (en) 2012-06-14 2015-06-18 Basf Se Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870161A (en) * 1957-07-08 1959-01-20 Pfizer & Co C 2-(1-indanyl amino)-oxazolines
US2870159A (en) * 1957-07-08 1959-01-20 Pfizer & Co C Hydrogenated 2-(1-naphthylamino)-oxazolines
US2883410A (en) * 1957-07-08 1959-04-21 Pfizer & Co C N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas
US3636219A (en) * 1964-03-02 1972-01-18 Du Pont Anticholinergic compositions containing certain thiazolines or imidazolines
AT330769B (de) * 1974-04-05 1976-07-26 Chemie Linz Ag Verfahren zur herstellung von 2-arylamino- 2-imidazolin-derivaten und ihren salzen
US4256755A (en) * 1980-04-28 1981-03-17 E. I. Du Pont De Nemours & Company Method of using N-substituted dihydro-2-oxazolamines as analgesics
GB8610909D0 (en) * 1986-05-03 1986-06-11 Beecham Group Plc Compounds
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
WO1996035424A1 (en) * 1995-05-12 1996-11-14 Allergan Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
WO2005055999A1 (ja) * 2003-12-08 2005-06-23 Nippon Shinyaku Co., Ltd. 抗コリン作用剤
GB0516706D0 (en) * 2005-08-15 2005-09-21 Syngenta Participations Ag Chemical compounds
PE20070705A1 (es) * 2005-11-25 2007-08-23 Basf Ag Compuestos de indanil - y tetrahidronaftil-amino-azolina para combatir pestes animales
BRPI0707868A2 (pt) * 2006-02-15 2011-05-10 Bayer Cropscience Ag inseticidas derivados de aminaheteroarila e heterocÍclicos substituÍdos, composiÇço inseticida e processo para o controle de insetos
WO2008115141A1 (en) * 2007-03-19 2008-09-25 Albireo Ab 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
BRPI0816158A2 (pt) * 2007-08-15 2017-06-13 Allergan Inc composto carbociclo fundido substituído com heterociclila e uso do mesmo.

Also Published As

Publication number Publication date
JP2014139175A (ja) 2014-07-31
JP2010536780A (ja) 2010-12-02
EP2188261A1 (en) 2010-05-26
US20110178143A1 (en) 2011-07-21
KR20100046256A (ko) 2010-05-06
WO2009023757A1 (en) 2009-02-19
CN101855213A (zh) 2010-10-06
RU2010108387A (ru) 2011-09-20
CA2696404A1 (en) 2009-02-19
CN101855213B (zh) 2014-09-10
RU2491278C2 (ru) 2013-08-27
AU2008286823A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
BRPI1016150A2 (pt) compostos heterocíclicos e seus usos.
BRPI0817881A2 (pt) Compostos orgânicos e seus usos
BRPI0923533A2 (pt) espaçador sinusal frontal
BRPI0922845A2 (pt) pirazol-4-n-alcoxicarboxamidas como microbiocidas
BRPI0919295A2 (pt) 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios.
BRPI0816075A2 (pt) 2-(fenil substituído)-6-amino-5-alcóxi, tioalcóxi e aminoalquil-4-pirimidinacarboxilatos e seus usos como herbicidas
BRPI0908502A2 (pt) aines oftálmicos como adjuvantes
DK2324831T3 (da) Pirfenidonterapi, som undgår fluvoxamin
BRPI1008899A2 (pt) derivados 3,3´-espiroindolinona como agentes anticâncer
BRPI0911594A2 (pt) di-hidropirazolonas substistuídas, seu processo de preparação e seu uso, bem como medicamentos
BRPI0910534A2 (pt) terapia antiviral
DE502008001632D1 (de) Karosserieaufbau
DK2173831T3 (da) Brøndbehandling
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
BRPI0911179A2 (pt) 2-alquinil-6-piridin-2-ilpiridazinonas, 2-alquinil-6-piridin-2-il-di-hidropiridazinonas, 2-alquinil-6-pirimidin-2-ilpiridazinonas e 2-alquinil-6-pirimidin-2-il-di-hidropiridazinonas e seus usos como fungicidas
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento
BRPI0818598A2 (pt) agentes terapêuticos - 802
BRPI0807804A2 (pt) " arilciclopentenos substituídos como agentes terapêuticos ".
BRPI0817618A2 (pt) Lactose macrocíclicas como fragrâncias
BRPI0910931A2 (pt) ciclopentanos substituídos terapêuticos
BRPI0910991A2 (pt) piperidinas substituídas como compostos terapêuticos
BRPI0918062A2 (pt) Tienilaminopirimidinas como fungicidas
BRPI0815500A2 (pt) compostos terapêuticos, bem como seus usos
BRPI0909764A2 (pt) compostos terapêuticos
CU23885B1 (es) Estratrienos 8-beta sustituidos como estrógenos de acción selectiva

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]